Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability
about
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans.Optimizing the clinical pharmacology of tuberculosis medications.Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.Rifapentine for the treatment of latent tuberculosis.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.
P2860
Q33735589-2CADD1F6-ADA4-47B5-9FA7-DFCEC9558E9CQ35607718-5D66D22A-B3AD-48C9-9FEE-7C22C2020ABAQ36157986-DED241FF-6ABD-4D4F-A374-73E2576753AEQ37120003-53B42326-6147-438A-A515-B3583A093852Q38542159-E399007F-7508-4577-B340-FB0D82A5D49FQ38851434-5DF92441-DBA9-421E-B777-3A8ABE13F0FDQ38933165-0A03C3B7-6C6E-441B-A7CA-CB230276DBBBQ40095703-A7E3256D-EB17-4240-9333-680C79D49305Q42688154-8C5511BC-58F3-4E71-A21D-1D1DFC864A26Q47332682-3C5201B0-EADC-4C3B-AC4D-170BDCB0E725Q52584725-A098EB12-5D89-40A0-903A-EC925EA4A12D
P2860
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Population pharmacokinetics of ...... clearance and bioavailability
@ast
Population pharmacokinetics of ...... clearance and bioavailability
@en
type
label
Population pharmacokinetics of ...... clearance and bioavailability
@ast
Population pharmacokinetics of ...... clearance and bioavailability
@en
prefLabel
Population pharmacokinetics of ...... clearance and bioavailability
@ast
Population pharmacokinetics of ...... clearance and bioavailability
@en
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... clearance and bioavailability
@en
P2093
Eric Nuermberger
Erin Bliven-Sizemore
Kelly E Dooley
Marc Weiner
Radojka M Savic
Susan E Dorman
William Burman
P2860
P304
P356
10.1128/AAC.01918-13
P407
P577
2014-03-10T00:00:00Z